All for One
Immunocore Technology Rouses All T-Cell Comers Against Tumor
By Anette Breindl
Friday, May 11, 2012
Researchers at British biotechnology firm Immunocore Ltd., with academic colleagues, have come up with a method to break T-cell tolerance to cancer cells and target tumor-specific proteins, even when those proteins are expressed at very low levels.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.